Okura Takafumi, Higaki Jitsuo
Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Japan.
Clin Calcium. 2010 Jan;20(1):61-8.
Ca channel blocker (CCB) is widely used as an anti-hypertensive and anti-ischemic heart disease drug in Japan. CCB or angiotensin receptor antagonist (ARB) is selected as a first line anti-hypertensive drug. However, mono-therapy is often insufficient and combination therapy is needed to achieve the adequate blood pressure control. Hypertensive patients are also sometimes combined with dyslipidemia. In these reasons, a single pill combination of CCB and ARB or statin play an important role in hypertensive and anti-atherosclerotic therapy.
钙通道阻滞剂(CCB)在日本被广泛用作抗高血压和抗缺血性心脏病药物。CCB或血管紧张素受体拮抗剂(ARB)被选为一线抗高血压药物。然而,单一疗法往往不足,需要联合治疗以实现充分的血压控制。高血压患者有时还合并血脂异常。基于这些原因,CCB与ARB或他汀类药物的单片复方制剂在高血压和抗动脉粥样硬化治疗中发挥着重要作用。